Duke University’s Master of International Translational Medicine (MITM) is a two-year, part-time programme designed for working professionals in healthcare and translational research. You’ll learn how to move discoveries from unmet clinical needs to real-world patient treatments through expert-led teaching and international networking.
Duke University offers a Master of International Translational Medicine (MITM), a two-year, part-time program tailored for healthcare professionals and those involved in translational research. This program equips students with the skills to translate discoveries into real-world medical treatments, featuring expert instruction and opportunities for international networking.
Format: The program is structured as part-time, executive-style learning, designed to accommodate the schedules of working professionals.
Core learning areas include:
Learning approach: The program emphasizes expert-led instruction, applied discussions on translational challenges, and structured learning throughout the translational pathway.
Assessment & capstone: Details regarding assessment methods are not specified. Prospective students should consult the admissions team for information on projects or exams.
Applicants should possess at least a Bachelor’s degree. There is no specific requirement for GRE or GMAT scores.
Graduates of the Master of International Translational Medicine program will be well-prepared for advanced roles in healthcare and translational research. The comprehensive curriculum, combined with networking opportunities, positions alumni for success in various sectors, including pharmaceuticals, biotechnology, and academic research.
Shortlist scholarships and plan your application — free guidance from our advisors.